Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS).
Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS
The study, led by researchers at the University of Cambridge, is a step towards developing personalised treatments based on a patient’s own skin cells for diseases of the central nervous system (CNS).
In MS, the body’s own immune system attacks and damages myelin, the protective sheath around nerve fibres, causing disruption to messages sent around the brain and spinal cord. Symptoms are unpredictable and include problems with mobility and balance, pain, and severe fatigue.
Key immune cells involved in causing this damage are macrophages (literally ‘big eaters’), which ordinarily serve to attack and rid the body of unwanted intruders. A particular type of macrophage known as microglia are found throughout the brain and spinal cord – in progressive forms of MS, they attack the CNS, causing chronic inflammation and damage to nerve cells.
Recent advances have raised expectations that diseases of the CNS may be improved by the use of stem cell therapies. Stem cells are the body’s ‘master cells’, which can develop into almost any type of cell within the body. Previous work from the Cambridge team has shown that transplanting neural stem cells (NSCs) – stem cells that are part-way to developing into nerve cells – reduces inflammation and can help the injured CNS heal.
However, even if such a therapy could be developed, it would be hindered by the fact that such NSCs are sourced from embryos and therefore cannot be obtained in large enough quantities. Also, there is a risk that the body will see them as an alien invader, triggering an immune response to destroy them.
A possible solution to this problem would be the use of so-called ‘induced neural stem cells (iNSCs)’ – these cells can be generated by taking an adult’s skin cells and ‘re-programming’ them back to become neural stem cells. As these iNSCs would be the patient’s own, they are less likely to trigger an immune response.
Now, in research published in the journal Cell Stem Cell, researchers at the University of Cambridge have shown that iNSCs may be a viable option to repairing some of the damage caused by MS.
Using mice that had been manipulated to develop MS, the researchers discovered that chronic MS leads to significantly increased levels of succinate, a small metabolite that sends signals to macrophages and microglia, tricking them into causing inflammation, but only in cerebrospinal fluid, not in the peripheral blood.
Transplanting NSCs and iNSCs directly into the cerebrospinal fluid reduces the amount of succinate, reprogramming the macrophages and microglia – in essence, turning ‘bad’ immune cells ‘good’. This leads to a decrease in inflammation and subsequent secondary damage to the brain and spinal cord.
“Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS,” says Dr Stefano Pluchino, lead author of the study from the Department of Clinical Neurosciences at the University of Cambridge.
“This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of an adverse immune response.”
The research team was led by Dr Pluchino, together with Dr Christian Frezza from the MRC Cancer Unit at the University of Cambridge, and brought together researchers from several university departments.
Dr Luca Peruzzotti-Jametti, the first author of the study and a Wellcome Trust Research Training Fellow, says: “We made this discovery by bringing together researchers from diverse fields including regenerative medicine, cancer, mitochondrial biology, inflammation and stroke and cellular reprogramming. Without this multidisciplinary collaboration, many of these insights would not have been possible.”
The Latest on: Personalised stem cell treatment
- Genetics study offers hope for new acne treatment on December 12, 2018 at 4:48 am
A discovery by researchers from the School of Basic & Medical Biosciences and NIHR Guy's and St Thomas' Biomedical Research Centre could lead to new treatments for severe acne. Scientists found 15 gen... […]
- GBMC forms center to hunt for treatments, cure for a rare genetic disease on December 7, 2018 at 2:34 pm
Greater Baltimore Medical Center has established the country’s first center for treatment of Alstrom Syndrome, an extremely rare genetic disease that does devastating harm to every system in the body, ... […]
- Orchard’s Gene Therapy for Rare Immune Disease Works for Over a Year on December 7, 2018 at 8:29 am
Originally developed by the Genethon Institute in France, this one-time treatment works by extracting the patient’s immune cells and providing them with a healthy copy of the mutated gene. To keep the ... […]
- Personalized Gene Therapy Treatments for Cancer Consumption Market: Impact of Existing and Emerging Flexible Market Trends and Forecast 2018-2025 on November 13, 2018 at 12:50 am
... person's genetic makeup and untangle the biologic nature of the patient's cancerous cells for carrying out such therapies." The analysts forecast the Personalized Gene Therapy Treatments For Cance... […]
- British research brings personalised treatment for blood cancer a step closer on November 12, 2018 at 8:48 am
Personalised treatments for leukaemia have come a step closer after a British study on the role gene mutations play in blood cancers. Scientists from the University of Birmingham analysed abnormal whi... […]
- "Lab on a chip" technology picks personalized cancer-fighting molecules out of a crowd on November 7, 2018 at 8:58 pm
... of receptor molecules on their surface that lock onto antigens on the surface of toxic cancer cells and begin to destroy them. Engineered T cell therapy is a form of cancer treatment where physici... […]
- Personalised drugs – the future of cancer treatment? on October 30, 2018 at 11:35 am
A self-powered biosensor could detect cancer cells, treat them, and evaluate how well the treatment has worked in real time, providing a quick and easy way to refine treatment methods – this could one ... […]
- Is the Next Big Step in Cancer Therapy Personalized Vaccines? on October 12, 2018 at 8:28 am
“T cells need to recognize a cancer cell as being different ... We are creating an incredibly personalized and precise therapy that is based on what that person’s cancer and immune system are telling ... […]
- Recent IPO Gritstone Oncology: Neoantigen Targeted Personalized T Cell Therapy In Cancers on October 12, 2018 at 6:44 am
GRTS data by YCharts Cancer neoantigens: a personalized form of immunotherapy ... also exploring modifying the receptors of the patients own T cells against tumor antigens (adoptive T cell therapy, th... […]
via Google News and Bing News